Yutaka Okuno

2.4k total citations
66 papers, 1.9k citations indexed

About

Yutaka Okuno is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Yutaka Okuno has authored 66 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 27 papers in Hematology and 12 papers in Immunology. Recurrent topics in Yutaka Okuno's work include Multiple Myeloma Research and Treatments (13 papers), Acute Myeloid Leukemia Research (13 papers) and Immune Cell Function and Interaction (8 papers). Yutaka Okuno is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Acute Myeloid Leukemia Research (13 papers) and Immune Cell Function and Interaction (8 papers). Yutaka Okuno collaborates with scholars based in Japan, United States and United Kingdom. Yutaka Okuno's co-authors include Daniel G. Tenen, Koichi Akashi, Hiromi Iwasaki, Hiroaki Mitsuya, Frank Rosenbauer, Hiroyuki Hata, Yawara Kawano, Jeffery L. Kutok, Katharina Wagner and Michelle M. Le Beau and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and The EMBO Journal.

In The Last Decade

Yutaka Okuno

62 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yutaka Okuno Japan 22 1.2k 694 511 391 278 66 1.9k
Jasper de Boer United Kingdom 22 1.2k 1.0× 477 0.7× 787 1.5× 342 0.9× 271 1.0× 43 2.2k
Camille Lobry United States 14 1.1k 1.0× 357 0.5× 504 1.0× 374 1.0× 320 1.2× 25 1.8k
Helena Jernberg‐Wiklund Sweden 26 1.3k 1.1× 651 0.9× 255 0.5× 556 1.4× 255 0.9× 60 2.0k
Alison M. Michie United Kingdom 27 1.2k 1.1× 463 0.7× 1.0k 2.0× 486 1.2× 304 1.1× 67 2.5k
Jason A. Powell Australia 24 1.0k 0.9× 288 0.4× 340 0.7× 318 0.8× 169 0.6× 42 1.6k
W. Michael Kuehl United States 14 2.1k 1.8× 1.2k 1.7× 322 0.6× 624 1.6× 294 1.1× 21 2.7k
Mark A. Gregory United States 16 1.5k 1.3× 335 0.5× 200 0.4× 567 1.5× 360 1.3× 21 1.9k
Marc A. Kerenyi United States 20 1.3k 1.1× 553 0.8× 863 1.7× 494 1.3× 196 0.7× 27 2.4k
Silvia Grisendi United States 8 1.7k 1.4× 597 0.9× 163 0.3× 358 0.9× 296 1.1× 12 2.1k
Ting-Lei Gu United States 12 1.6k 1.4× 513 0.7× 286 0.6× 277 0.7× 714 2.6× 12 2.1k

Countries citing papers authored by Yutaka Okuno

Since Specialization
Citations

This map shows the geographic impact of Yutaka Okuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Okuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Okuno more than expected).

Fields of papers citing papers by Yutaka Okuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Okuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Okuno. The network helps show where Yutaka Okuno may publish in the future.

Co-authorship network of co-authors of Yutaka Okuno

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Okuno. A scholar is included among the top collaborators of Yutaka Okuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Okuno. Yutaka Okuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yano, Hiromu, Yukio Fujiwara, Hasita Horlad, et al.. (2022). Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy. Cancer Science. 113(6). 2129–2143. 13 indexed citations
2.
Fujimoto, Yuki, Shikiko Ueno, Kazutaka Oda, et al.. (2021). Relationship between Serum Bortezomib Concentration and Emergence of Diarrhea in Patients with Multiple Myeloma and/or AL Amyloidosis. Cancers. 13(22). 5674–5674.
3.
Ueno, Shikiko, Yawara Kawano, Yoshitaka Kikukawa, et al.. (2019). [Spontaneous remission of acquired factor XIII inhibitor concurrent to development of IgA-λ type multiple myeloma].. PubMed. 60(10). 1443–1448. 1 indexed citations
4.
Nishimura, Nao, Mohamed O. Radwan, Masayuki Amano, et al.. (2019). Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib‐sensitive and ‐resistant multiple myeloma cells. Cancer Science. 110(10). 3275–3287. 26 indexed citations
5.
Nishimura, Nao, Shinya Endo, Shiho Fujiwara, et al.. (2018). Bufalin induces DNA damage response under hypoxic condition in myeloma cells. Oncology Letters. 15(5). 6443–6449. 7 indexed citations
6.
Endo, Shinya, Nao Nishimura, Yawara Kawano, et al.. (2018). MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cells. Biochemical and Biophysical Research Communications. 507(1-4). 246–252. 6 indexed citations
7.
Hata, Hiroyuki, Mitsuharu Ueda, Nao Nishimura, et al.. (2017). Amyloid Fibril Formation of Immunoglobulin Light Chain Peptide from IHC-Negative AL Amyloidosis and Its Inhibition By Doxycycline and Epigallocatechin. Blood. 130. 5331–5331. 1 indexed citations
8.
Nishimura, Nao, Shinya Endo, Shiho Fujiwara, et al.. (2017). Identification of a Compound Overcoming Drug Resistance of Myeloma Cells at Hypoxic Condition. Blood. 130. 5395–5395. 1 indexed citations
9.
Tokunaga, Kenji, Shikiko Ueno, Yoshitaka Kikukawa, et al.. (2017). Isolated Pancreatic Myeloid Sarcoma Associated with t(8;21)/<i>RUNX1-RUNX1T1</i> Rearrangement. Internal Medicine. 57(4). 563–568. 6 indexed citations
10.
Goto, Hiroki, Ryusho Kariya, Eriko Kudo, et al.. (2017). Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma. Oncogene. 36(37). 5252–5262. 10 indexed citations
11.
Fujiwara, Shiho, Hirotomo Nakata, Koichi Ohshima, et al.. (2016). Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids. International Journal of Hematology. 103(6). 718–723. 38 indexed citations
12.
Wada, Naoko, Yawara Kawano, Shiho Fujiwara, et al.. (2014). Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells. International Journal of Oncology. 46(3). 963–972. 61 indexed citations
13.
Nosaka, Kisato, et al.. (2014). An Evaluation of the Incidence of Adverse Events by Subcutaneous Versus Intravenous Administration of Bortezomib. Annals of Oncology. 25. v83–v83. 1 indexed citations
14.
Kikukawa, Yoshitaka, Hirotomo Nakata, Toshikazu Miyakawa, et al.. (2014). Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study. International Journal of Hematology. 101(2). 133–139. 9 indexed citations
15.
Kawano, Yawara, Yoshitaka Kikukawa, Shiho Fujiwara, et al.. (2013). Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells. International Journal of Oncology. 43(6). 1809–1816. 44 indexed citations
16.
Kawano, Yawara, Shiho Fujiwara, Naoko Wada, et al.. (2012). Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide. International Journal of Oncology. 41(3). 876–884. 82 indexed citations
17.
Tatetsu, Hiro, Shikiko Ueno, Hiroyuki Hata, et al.. (2007). Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth. Cancer Research. 67(11). 5328–5336. 41 indexed citations
18.
Nakamura, Miki, Tomomi Gotoh, Yutaka Okuno, et al.. (2006). Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells. Leukemia & lymphoma. 47(3). 531–539. 55 indexed citations
19.
Okuno, Yutaka, Hiromi Iwasaki, Claudia S. Huettner, et al.. (2002). Differential regulation of the human and murine CD34 genes in hematopoietic stem cells. Proceedings of the National Academy of Sciences. 99(9). 6246–6251. 62 indexed citations
20.
Shiomi, Tadahiro, et al.. (1994). An ERCC5 gene with homology to yeast RAD2 is involved in group G xeroderma pigmentosum. Mutation Research/DNA Repair. 314(2). 167–175. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jasper de Boer Breakdown of academic impact, for papers by Camille Lobry Breakdown of academic impact, for papers by Helena Jernberg‐Wiklund Breakdown of academic impact, for papers by Alison M. Michie Breakdown of academic impact, for papers by Jason A. Powell Breakdown of academic impact, for papers by W. Michael Kuehl Breakdown of academic impact, for papers by Mark A. Gregory Breakdown of academic impact, for papers by Marc A. Kerenyi Breakdown of academic impact, for papers by Silvia Grisendi Breakdown of academic impact, for papers by Ting-Lei Gu
Rankless by CCL
2026